Ikonisys SA Cash Flow Conversion Efficiency
Ikonisys SA cash flow conversion efficiency. Based on the latest financial reports, Ikonisys SA (ALIKO) has a cash flow conversion efficiency ratio of -0.016x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-257.48K ≈ $-301.02K USD) by net assets (€15.73 Million ≈ $18.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ikonisys SA (2020–2024)
Cash flow conversion efficiency of Ikonisys SA from 2020 to 2024. This chart illustrates how Ikonisys SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ikonisys SA stock quote for real-time trading data and today's change.
Ikonisys SA Cash Flow Conversion Ratio Explained
Ikonisys SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ikonisys SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikonisys SA ranked by their cash flow conversion efficiency. Also see how much is Ikonisys SA worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nucletron Electronic Aktiengesellschaft
F:NUC
|
0.004x |
|
AIxCrypto Holdings, Inc.
NASDAQ:AIXC
|
-0.606x |
|
Schlatter Industries AG
SW:STRN
|
-0.197x |
|
Zee Learn Limited
NSE:ZEELEARN
|
0.024x |
|
PLYTEC Holding Berhad
KLSE:0289
|
0.064x |
|
Naas Technology Inc ADR
NASDAQ:NAAS
|
-0.015x |
|
Huachen AI Parking Management Technology Holding Co Ltd
NASDAQ:HCAI
|
-1.045x |
|
BBC Co. Ltd.
KQ:318410
|
0.013x |
Annual Cash Flow Conversion Efficiency for Ikonisys SA (2020–2024)
The table below shows the annual cash flow conversion efficiency of Ikonisys SA from 2020 to 2024. Review Ikonisys SA financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €14.25 Million ≈ $16.66 Million |
€-1.33 Million ≈ $-1.55 Million |
-0.093x | -60.43% |
| 2023-12-31 | €15.73 Million ≈ $18.39 Million |
€-914.22K ≈ $-1.07 Million |
-0.058x | +9.72% |
| 2022-12-31 | €17.67 Million ≈ $20.66 Million |
€-1.14 Million ≈ $-1.33 Million |
-0.064x | -64.86% |
| 2021-12-31 | €20.01 Million ≈ $23.40 Million |
€-781.42K ≈ $-913.56K |
-0.039x | +85.34% |
| 2020-12-31 | €5.70 Million ≈ $6.66 Million |
€-1.52 Million ≈ $-1.77 Million |
-0.266x | -- |
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more